{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:04:22Z","timestamp":1791896662587,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2005,5,29]],"date-time":"2005-05-29T00:00:00Z","timestamp":1117324800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1038\/ng1581","type":"journal-article","created":{"date-parts":[[2005,5,29]],"date-time":"2005-05-29T13:16:49Z","timestamp":1117372609000},"page":"692-700","source":"Crossref","is-referenced-by-count":196,"title":["Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations"],"prefix":"10.1038","volume":"37","author":[{"given":"Guillaume","family":"Vogt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"Chapgier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Chuzhanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Feinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Fieschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Boisson-Dupuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Alcais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orchid\u00e9e","family":"Filipe-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacinta","family":"Bustamante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"de Beaucoudrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Al-Mohsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Al-Hajjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulaziz","family":"Al-Ghonaium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parisa","family":"Adimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Mirsaeidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soheila","family":"Khalilzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Rosenzweig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"de la Calle Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M","family":"Puck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans D","family":"Ochs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Furthner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Engelhorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Belohradsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davood","family":"Mansouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Abel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Soudais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Laurent","family":"Casanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,5,29]]},"reference":[{"key":"BFng1581_CR1","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1146\/annurev.immunol.20.081501.125851","volume":"20","author":"JL Casanova","year":"2002","unstructured":"Casanova, J.L. & Abel, L. Genetic dissection of immunity to mycobacteria: the human model. Annu. Rev. Immunol. 20, 581\u2013620 (2002).","journal-title":"Annu. Rev. Immunol."},{"key":"BFng1581_CR2","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1056\/NEJM199612263352602","volume":"335","author":"MJ Newport","year":"1996","unstructured":"Newport, M.J. et al. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335, 1941\u20131949 (1996).","journal-title":"N. Engl. J. Med."},{"key":"BFng1581_CR3","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1056\/NEJM199612263352604","volume":"335","author":"E Jouanguy","year":"1996","unstructured":"Jouanguy, E. et al. Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection. N. Engl. J. Med. 335, 1956\u20131961 (1996).","journal-title":"N. Engl. J. Med."},{"key":"BFng1581_CR4","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1172\/JCI2901","volume":"101","author":"SE Dorman","year":"1998","unstructured":"Dorman, S.E. & Holland, S.M. Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. J. Clin. Invest. 101, 2364\u20132369 (1998).","journal-title":"J. Clin. Invest."},{"key":"BFng1581_CR5","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1172\/JCI4950","volume":"102","author":"F Altare","year":"1998","unstructured":"Altare, F. et al. Inherited interleukin 12 deficiency in a child with bacille Calmette-Gu\u00e9rin and Salmonella enteritidis disseminated infection. J. Clin. Invest. 102, 2035\u20132040 (1998).","journal-title":"J. Clin. Invest."},{"key":"BFng1581_CR6","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1126\/science.280.5368.1432","volume":"280","author":"F Altare","year":"1998","unstructured":"Altare, F. et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 280, 1432\u20131435 (1998).","journal-title":"Science"},{"key":"BFng1581_CR7","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1126\/science.280.5368.1435","volume":"280","author":"R de Jong","year":"1998","unstructured":"de Jong, R. et al. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 280, 1435\u20131438 (1998).","journal-title":"Science"},{"key":"BFng1581_CR8","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1126\/science.1061154","volume":"293","author":"S Dupuis","year":"2001","unstructured":"Dupuis, S. et al. Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Science 293, 300\u2013303 (2001).","journal-title":"Science"},{"key":"BFng1581_CR9","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1182\/blood-2004-02-0584","volume":"104","author":"C Fieschi","year":"2004","unstructured":"Fieschi, C. et al. A novel form of complete IL-12\/IL-23 receptor beta1-deficiency with cell surface-expressed non-functional receptors. Blood 104, 2095\u20132101 (2004).","journal-title":"Blood"},{"key":"BFng1581_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nri1264","volume":"4","author":"JL Casanova","year":"2004","unstructured":"Casanova, J.L. & Abel, L. The human model: a genetic dissection of immunity to infection in natural conditions. Nat. Rev. Immunol. 4, 56\u201366 (2004).","journal-title":"Nat. Rev. Immunol."},{"key":"BFng1581_CR11","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1172\/JCI9166","volume":"105","author":"E Jouanguy","year":"2000","unstructured":"Jouanguy, E. et al. In a novel form of complete IFN\u03b3R1 deficiency, cell-surface receptors fail to bind IFN\u03b3. J. Clin. Invest. 105, 1429\u20131436 (2000).","journal-title":"J. Clin. Invest."},{"key":"BFng1581_CR12","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1172\/JCI119810","volume":"100","author":"E Jouanguy","year":"1997","unstructured":"Jouanguy, E. et al. Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guerin infection and a sibling with clinical tuberculosis. J. Clin. Invest. 100, 2658\u20132664 (1997).","journal-title":"J. Clin. Invest."},{"key":"BFng1581_CR13","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/7701","volume":"21","author":"E Jouanguy","year":"1999","unstructured":"Jouanguy, E. et al. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat. Genet. 21, 370\u2013378 (1999).","journal-title":"Nat. Genet."},{"key":"BFng1581_CR14","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1086\/315197","volume":"181","author":"R D\u00f6ffinger","year":"2000","unstructured":"D\u00f6ffinger, R. et al. Partial interferon gamma receptor signalling chain deficiency in a patient with bacille Calmette-Gu\u00e9rin and Mycobacterium abscessus infection. J. Infect. Dis. 181, 379\u2013384 (2000).","journal-title":"J. Infect. Dis."},{"key":"BFng1581_CR15","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1016\/S0140-6736(04)17552-1","volume":"364","author":"SE Dorman","year":"2004","unstructured":"Dorman, S.E. et al. Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies. Lancet 364, 2113\u20132121 (2004).","journal-title":"Lancet"},{"key":"BFng1581_CR16","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/ng1097","volume":"33","author":"S Dupuis","year":"2003","unstructured":"Dupuis, S. et al. Impaired response to interferon-alpha\/beta and lethal viral disease in human STAT1 deficiency. Nat. Genet. 33, 388\u2013391 (2003).","journal-title":"Nat. Genet."},{"key":"BFng1581_CR17","doi-asserted-by":"publisher","first-page":"4000","DOI":"10.4049\/jimmunol.173.6.4000","volume":"173","author":"SD Rosenzweig","year":"2004","unstructured":"Rosenzweig, S.D. et al. A novel mutation in IFN-gamma receptor 2 with dominant negative activity: biological consequences of homozygous and heterozygous states. J. Immunol. 173, 4000\u20134008 (2004).","journal-title":"J. Immunol."},{"key":"BFng1581_CR18","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.1002\/eji.200425221","volume":"34","author":"J Feinbezzzrg","year":"2004","unstructured":"Feinbezzzrg, J. et al. Bacillus Calmette Guerin triggers the IL-12\/IFN-gamma axis by an IRAK-4- and NEMO-dependent, non-cognate interaction between monocytes, NK, and T lymphocytes. Eur. J. Immunol. 34, 3276\u20133284 (2004).","journal-title":"Eur. J. Immunol."},{"key":"BFng1581_CR19","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1146\/annurev.biochem.72.121801.161809","volume":"72","author":"JB Lowe","year":"2003","unstructured":"Lowe, J.B. & Marth, J.D. A genetic approach to Mammalian glycan function. Annu. Rev. Biochem. 72, 643\u2013691 (2003).","journal-title":"Annu. Rev. Biochem."},{"key":"BFng1581_CR20","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0003-2697(89)90115-2","volume":"180","author":"F Maley","year":"1989","unstructured":"Maley, F., Trimble, R.B., Tarentino, A.L. & Plummer, T.H. Jr Characterization of glycoproteins and their associated oligosaccharides through the use of endoglycosidases. Anal. Biochem. 180, 195\u2013204 (1989).","journal-title":"Anal. Biochem."},{"key":"BFng1581_CR21","doi-asserted-by":"publisher","first-page":"93R","DOI":"10.1093\/glycob\/cwg090","volume":"13","author":"N Asano","year":"2003","unstructured":"Asano, N. Glycosidase inhibitors: update and perspectives on practical use. Glycobiology 13, 93R\u2013104R (2003).","journal-title":"Glycobiology"},{"key":"BFng1581_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1023\/A:1006100929670","volume":"54","author":"M Becchis","year":"1999","unstructured":"Becchis, M. et al. The additionally glycosylated variant of human sex hormone-binding globulin (SHBG) is linked to estrogen-dependence of breast cancer. Breast Cancer Res. Treat. 54, 101\u2013107 (1999).","journal-title":"Breast Cancer Res. Treat."},{"key":"BFng1581_CR23","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/hmg\/11.3.301","volume":"11","author":"PR Manna","year":"2002","unstructured":"Manna, P.R. et al. Synthesis, purification and structural and functional characterization of recombinant form of a common genetic variant of human luteinizing hormone. Hum. Mol. Genet. 11, 301\u2013315 (2002).","journal-title":"Hum. Mol. Genet."},{"key":"BFng1581_CR24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1515\/9783110871951-012","volume-title":"Fibrinogen-Fibrin Formation and Fibrinolysis","author":"H Kaudewitz","year":"1986","unstructured":"Kaudewitz, H., Henschen, A., Soria, J. & Soria, C. Fibrinogen Pontoise A genetically abnormal fibrinogen with defective fibrin polymerisation but normal fibrinopeptide release. in Fibrinogen-Fibrin Formation and Fibrinolysis vol. 4 (eds. Lane, D.A., Henschen, A. & Jasani, H.K.) 91\u201396 (Walter de Gruyter, Berlin, 1986)."},{"key":"BFng1581_CR25","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1172\/JCI114056","volume":"83","author":"K Yamazumi","year":"1989","unstructured":"Yamazumi, K., Shimura, K., Terukina, S., Takahashi, N. & Matsuda, M. A gamma methionine-310 to threonine substitution and consequent N-glycosylation at gamma asparagine-308 identified in a congenital dysfibrinogenemia associated with posttraumatic bleeding, fibrinogen Asahi. J. Clin. Invest. 83, 1590\u20131597 (1989).","journal-title":"J. Clin. Invest."},{"key":"BFng1581_CR26","doi-asserted-by":"publisher","first-page":"6786","DOI":"10.1073\/pnas.87.17.6786","volume":"87","author":"RB Parad","year":"1990","unstructured":"Parad, R.B., Kramer, J., Strunk, R.C., Rosen, F.S. & Davis, A.E. 3rd Dysfunctional C1 inhibitor Ta: deletion of Lys-251 results in acquisition of an N-glycosylation site. Proc. Natl. Acad. Sci. USA 87, 6786\u20136790 (1990).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng1581_CR27","doi-asserted-by":"crossref","first-page":"11575","DOI":"10.1016\/S0021-9258(18)98995-7","volume":"266","author":"H Maekawa","year":"1991","unstructured":"Maekawa, H. et al. An A alpha Ser-434 to N-glycosylated Asn substitution in a dysfibrinogen, fibrinogen Caracas II, characterized by impaired fibrin gel formation. J. Biol. Chem. 266, 11575\u2013115781 (1991).","journal-title":"J. Biol. Chem."},{"key":"BFng1581_CR28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1172\/JCI115857","volume":"90","author":"H Maekawa","year":"1992","unstructured":"Maekawa, H. et al. Fibrinogen Lima: a homozygous dysfibrinogen with an A alpha-arginine-141 to serine substitution associated with extra N-glycosylation at A alpha-asparagine-139. Impaired fibrin gel formation but normal fibrin-facilitated plasminogen activation catalyzed by tissue-type plasminogen activator. J. Clin. Invest. 90, 67\u201376 (1992).","journal-title":"J. Clin. Invest."},{"key":"BFng1581_CR29","doi-asserted-by":"publisher","first-page":"4933","DOI":"10.1073\/pnas.89.11.4933","volume":"89","author":"AM Aly","year":"1992","unstructured":"Aly, A.M. et al. Hemophilia A due to mutations that create new N-glycosylation sites. Proc. Natl. Acad. Sci. USA 89, 4933\u20134937 (1992).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng1581_CR30","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1006\/geno.1996.0492","volume":"36","author":"L Lonnqvist","year":"1996","unstructured":"Lonnqvist, L. et al. A point mutation creating an extra N-glycosylation site in fibrillin-1 results in neonatal Marfan syndrome. Genomics 36, 468\u2013475 (1996).","journal-title":"Genomics"},{"key":"BFng1581_CR31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0014-5793(96)01134-9","volume":"397","author":"R Pariyarath","year":"1996","unstructured":"Pariyarath, R., Pagani, F., Stuani, C., Garcia, R. & Baralle, F.E. L273S missense substitution in human lysosomal acid lipase creates a new N-glycosylation site. FEBS Lett. 397, 79\u201382 (1996).","journal-title":"FEBS Lett."},{"key":"BFng1581_CR32","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1046\/j.1365-2141.1997.4363246.x","volume":"99","author":"HJ Ridgway","year":"1997","unstructured":"Ridgway, H.J., Brennan, S.O., Loreth, R.M. & George, P.M. Fibrinogen Kaiserslautern (gamma 380 Lys to Asn): a new glycosylated fibrinogen variant with delayed polymerization. Br. J. Haematol. 99, 562\u2013569 (1997).","journal-title":"Br. J. Haematol."},{"key":"BFng1581_CR33","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1182\/blood.V94.11.3806","volume":"94","author":"T Sugo","year":"1999","unstructured":"Sugo, T. et al. Fibrinogen Niigata with impaired fibrin assembly: an inherited dysfibrinogen with a Bbeta Asn-160 to Ser substitution associated with extra glycosylation at Bbeta Asn-158. Blood 94, 3806\u20133813 (1999).","journal-title":"Blood"},{"key":"BFng1581_CR34","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1023\/A:1010992827511","volume":"17","author":"MM Hammerle","year":"2000","unstructured":"Hammerle, M.M., Aleksandrov, A.A., Chang, X.B. & Riordan, J.R. A novel CFTR disease-associated mutation causes addition of an extra N-linked oligosaccharide. Glycoconj. J. 17, 807\u2013813 (2000).","journal-title":"Glycoconj. J."},{"key":"BFng1581_CR35","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1055\/s-0037-1616528","volume":"86","author":"AC Fitches","year":"2001","unstructured":"Fitches, A.C., Lewandowski, K. & Olds, R.J. Creation of an additional glycosylation site as a mechanism for type I antithrombin deficiency. Thromb. Haemost. 86, 1023\u20131027 (2001).","journal-title":"Thromb. Haemost."},{"key":"BFng1581_CR36","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1182\/blood-2003-06-2092","volume":"103","author":"M Steen","year":"2004","unstructured":"Steen, M. et al. Functional characterization of factor V-Ile359Thr: a novel mutation associated with thrombosis. Blood 103, 3381\u20133387 (2004).","journal-title":"Blood"},{"key":"BFng1581_CR37","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1182\/blood-2003-07-2569","volume":"103","author":"A Hamano","year":"2004","unstructured":"Hamano, A. et al. Thrombophilic dysfibrinogen Tokyo V with the amino acid substitution of gammaAla327Thr: formation of fragile but fibrinolysis-resistant fibrin clots and its relevance to arterial thromboembolism. Blood 103, 3045\u20133050 (2004).","journal-title":"Blood"},{"key":"BFng1581_CR38","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/0470092645.ch8","volume":"255","author":"RS Molday","year":"2004","unstructured":"Molday, R.S., Molday, L.L. & Loewen, C.J. Role of subunit assembly in autosomal dominant retinitis pigmentosa linked to mutations in peripherin 2. Novartis Found. Symp. 255, 95\u2013112 (2004).","journal-title":"Novartis Found. Symp."},{"key":"BFng1581_CR39","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/humu.10212","volume":"21","author":"PD Stenson","year":"2003","unstructured":"Stenson, P.D. et al. Human Gene Mutation Database (HGMD): 2003 update. Hum. Mutat. 21, 577\u2013581 (2003).","journal-title":"Hum. Mutat."},{"key":"BFng1581_CR40","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.jmb.2004.03.016","volume":"338","author":"L Kall","year":"2004","unstructured":"Kall, L., Krogh, A. & Sonnhammer, E.L. A combined transmembrane topology and signal peptide prediction method. J. Mol. Biol. 338, 1027\u20131036 (2004).","journal-title":"J. Mol. Biol."},{"key":"BFng1581_CR41","doi-asserted-by":"publisher","first-page":"22787","DOI":"10.1074\/jbc.R400002200","volume":"279","author":"NN Alder","year":"2004","unstructured":"Alder, N.N. & Johnson, A.E. Cotranslational membrane protein biogenesis at the endoplasmic reticulum. J. Biol. Chem. 279, 22787\u201322790 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFng1581_CR42","first-page":"1968","volume":"89","author":"JM Puck","year":"1997","unstructured":"Puck, J.M. et al. Mutation analysis of IL2RG in human X-linked severe combined immunodeficiency. Blood 89, 1968\u20131977 (1997).","journal-title":"Blood"},{"key":"BFng1581_CR43","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1172\/JCI10993","volume":"108","author":"O de la Calle-Martin","year":"2001","unstructured":"de la Calle-Martin, O. et al. Familial CD8 deficiency due to a mutation in the CD8 alpha gene. J. Clin. Invest. 108, 117\u2013123 (2001).","journal-title":"J. Clin. Invest."},{"key":"BFng1581_CR44","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1006\/bbrc.1993.1712","volume":"193","author":"AL Back","year":"1993","unstructured":"Back, A.L. et al. A point mutation associated with leukocyte adhesion deficiency type 1 of moderate severity. Biochem. Biophys. Res. Commun. 193, 912\u2013918 (1993).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFng1581_CR45","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1136\/jmg.38.9.643","volume":"38","author":"R Clementi","year":"2001","unstructured":"Clementi, R. et al. Six novel mutations in the PRF1 gene in children with haemophagocytic lymphohistiocytosis. J. Med. Genet. 38, 643\u2013646 (2001).","journal-title":"J. Med. Genet."},{"key":"BFng1581_CR46","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1002\/pro.5560050316","volume":"5","author":"J Bajorath","year":"1996","unstructured":"Bajorath, J., Seyama, K., Nonoyama, S., Ochs, H.D. & Aruffo, A. Classification of mutations in the human CD40 ligand, gp39, that are associated with X-linked hyper IgM syndrome. Protein Science 5, 531 (1996).","journal-title":"Protein Science"},{"key":"BFng1581_CR47","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1126\/science.7679801","volume":"259","author":"RC Allen","year":"1993","unstructured":"Allen, R.C. et al. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259, 990\u2013993 (1993).","journal-title":"Science"},{"key":"BFng1581_CR48","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1074\/jbc.273.1.568","volume":"273","author":"Y Lu","year":"1998","unstructured":"Lu, Y. et al. Co- and posttranslational translocation mechanisms direct cystic fibrosis transmembrane conductance regulator N terminus transmembrane assembly. J. Biol. Chem. 273, 568\u2013576 (1998).","journal-title":"J. Biol. Chem."},{"key":"BFng1581_CR49","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1126\/science.1093941","volume":"304","author":"ME Egan","year":"2004","unstructured":"Egan, M.E. et al. Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects. Science 304, 600\u2013602 (2004).","journal-title":"Science"},{"key":"BFng1581_CR50","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1080\/10409239891204198","volume":"33","author":"P Van den Steen","year":"1998","unstructured":"Van den Steen, P., Rudd, P.M., Dwek, R.A. & Opdenakker, G. Concepts and principles of O-linked glycosylation. Crit. Rev. Biochem. Mol. Biol. 33, 151\u2013208 (1998).","journal-title":"Crit. Rev. Biochem. Mol. Biol."}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ng1581.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng1581","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng1581.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T05:31:49Z","timestamp":1706247109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ng1581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,29]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["BFng1581"],"URL":"https:\/\/doi.org\/10.1038\/ng1581","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1001700.323261","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1001700.325272","asserted-by":"object"}]},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5,29]]}}}